日本血液学会造血与淋巴组织肿瘤指南：白血病1. 急性髓系白血病（AML）。 - Suppr

Suppr

超能文献

JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML).

作者信息

Miyawaki Shuichi

机构信息

Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, 2-8-1, Minamiohtsuka, Toshima-ku, Tokyo, 170-8476, Japan.

出版信息

Int J Hematol. 2017 Sep;106(3):310-325. doi: 10.1007/s12185-017-2303-4. Epub 2017 Aug 7.

DOI:10.1007/s12185-017-2303-4

PMID:28786079

Abstract

摘要

相似文献

JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML).

Int J Hematol. 2017 Sep;106(3):310-325. doi: 10.1007/s12185-017-2303-4. Epub 2017 Aug 7.

JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia: 2. Acute promyelocytic leukemia (APL).

Int J Hematol. 2017 Oct;106(4):459-470. doi: 10.1007/s12185-017-2318-x. Epub 2017 Aug 30.

Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Pediatr Blood Cancer. 2020 Dec;67(12):e28692. doi: 10.1002/pbc.28692. Epub 2020 Sep 4.

[Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].

Rinsho Ketsueki. 2014 Jan;55(1):31-41.

Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.

Ann Hematol. 2014 Dec;93(12):2011-8. doi: 10.1007/s00277-014-2143-8. Epub 2014 Jul 4.

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

J Clin Oncol. 2014 Jan 20;32(3):219-28. doi: 10.1200/JCO.2013.51.8571. Epub 2013 Dec 2.

[Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].

Rinsho Ketsueki. 2009 Aug;50(8):611-6.

Acute myeloid leukemia.

Pediatr Clin North Am. 2008 Feb;55(1):21-51, ix. doi: 10.1016/j.pcl.2007.11.003.

Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?

Ann Hematol. 2017 Mar;96(3):363-371. doi: 10.1007/s00277-016-2899-0. Epub 2016 Dec 23.

Hydroxyurea prior to intensive chemotherapy in AML with moderate leukocytosis.

Leuk Res. 2018 Dec;75:7-10. doi: 10.1016/j.leukres.2018.10.015. Epub 2018 Oct 31.

引用本文的文献

TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation.

Cancer Sci. 2025 Mar;116(3):698-709. doi: 10.1111/cas.16431. Epub 2024 Dec 26.

Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.

Jpn J Clin Oncol. 2023 Jun 29;53(7):595-603. doi: 10.1093/jjco/hyad027.

Development and Effects of Leukemia Nursing Simulation Based on Clinical Reasoning.

Int J Environ Res Public Health. 2021 Apr 15;18(8):4190. doi: 10.3390/ijerph18084190.

Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway.

Int J Hematol. 2019 Aug;110(2):213-227. doi: 10.1007/s12185-019-02667-1. Epub 2019 May 25.

Treatment patterns and healthcare resource utilization in patients with FLT3-mutated and wild-type acute myeloid leukemia: A medical chart study.

Eur J Haematol. 2019 Apr;102(4):341-350. doi: 10.1111/ejh.13205. Epub 2019 Feb 5.

Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.

Int J Hematol. 2018 Sep;108(3):282-289. doi: 10.1007/s12185-018-2463-x. Epub 2018 May 9.

Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.

Int J Hematol. 2018 Sep;108(3):246-253. doi: 10.1007/s12185-018-2464-9. Epub 2018 May 8.

Hematopoietic stem cell transplantation for acute myeloid leukemia.

Int J Hematol. 2018 May;107(5):513-518. doi: 10.1007/s12185-018-2412-8. Epub 2018 Jan 27.

Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).

Int J Hematol. 2018 Aug;108(2):208-212. doi: 10.1007/s12185-017-2387-x. Epub 2017 Dec 20.

Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.

Int J Hematol. 2018 Apr;107(4):468-477. doi: 10.1007/s12185-017-2389-8. Epub 2017 Dec 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML).

作者信息

Miyawaki Shuichi

机构信息

Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, 2-8-1, Minamiohtsuka, Toshima-ku, Tokyo, 170-8476, Japan.

出版信息

Int J Hematol. 2017 Sep;106(3):310-325. doi: 10.1007/s12185-017-2303-4. Epub 2017 Aug 7.

DOI:10.1007/s12185-017-2303-4

PMID:28786079

Abstract

摘要

相似文献

JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML).

Int J Hematol. 2017 Sep;106(3):310-325. doi: 10.1007/s12185-017-2303-4. Epub 2017 Aug 7.

JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia: 2. Acute promyelocytic leukemia (APL).

Int J Hematol. 2017 Oct;106(4):459-470. doi: 10.1007/s12185-017-2318-x. Epub 2017 Aug 30.

Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Pediatr Blood Cancer. 2020 Dec;67(12):e28692. doi: 10.1002/pbc.28692. Epub 2020 Sep 4.

[Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].

Rinsho Ketsueki. 2014 Jan;55(1):31-41.

Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.

Ann Hematol. 2014 Dec;93(12):2011-8. doi: 10.1007/s00277-014-2143-8. Epub 2014 Jul 4.

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

J Clin Oncol. 2014 Jan 20;32(3):219-28. doi: 10.1200/JCO.2013.51.8571. Epub 2013 Dec 2.

[Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].

Rinsho Ketsueki. 2009 Aug;50(8):611-6.

Acute myeloid leukemia.

Pediatr Clin North Am. 2008 Feb;55(1):21-51, ix. doi: 10.1016/j.pcl.2007.11.003.

Ann Hematol. 2017 Mar;96(3):363-371. doi: 10.1007/s00277-016-2899-0. Epub 2016 Dec 23.

Hydroxyurea prior to intensive chemotherapy in AML with moderate leukocytosis.

Leuk Res. 2018 Dec;75:7-10. doi: 10.1016/j.leukres.2018.10.015. Epub 2018 Oct 31.

引用本文的文献

TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation.

Cancer Sci. 2025 Mar;116(3):698-709. doi: 10.1111/cas.16431. Epub 2024 Dec 26.

Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.

Jpn J Clin Oncol. 2023 Jun 29;53(7):595-603. doi: 10.1093/jjco/hyad027.

Development and Effects of Leukemia Nursing Simulation Based on Clinical Reasoning.

Int J Environ Res Public Health. 2021 Apr 15;18(8):4190. doi: 10.3390/ijerph18084190.

Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway.

Int J Hematol. 2019 Aug;110(2):213-227. doi: 10.1007/s12185-019-02667-1. Epub 2019 May 25.

Treatment patterns and healthcare resource utilization in patients with FLT3-mutated and wild-type acute myeloid leukemia: A medical chart study.

Eur J Haematol. 2019 Apr;102(4):341-350. doi: 10.1111/ejh.13205. Epub 2019 Feb 5.

Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.

Int J Hematol. 2018 Sep;108(3):282-289. doi: 10.1007/s12185-018-2463-x. Epub 2018 May 9.

Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.

Int J Hematol. 2018 Sep;108(3):246-253. doi: 10.1007/s12185-018-2464-9. Epub 2018 May 8.

Hematopoietic stem cell transplantation for acute myeloid leukemia.

Int J Hematol. 2018 May;107(5):513-518. doi: 10.1007/s12185-018-2412-8. Epub 2018 Jan 27.

Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).

Int J Hematol. 2018 Aug;108(2):208-212. doi: 10.1007/s12185-017-2387-x. Epub 2017 Dec 20.

Int J Hematol. 2018 Apr;107(4):468-477. doi: 10.1007/s12185-017-2389-8. Epub 2017 Dec 14.